![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Long-term Safety and Efficacy of
Emtricitabine/Tenofovir Alafenamide (F/TAF) With a
Third Agent in Children Living With HIV
|
|
|
AIDS 2022 July 29-Aug 1 Montreal
Renate Strehlau,1 Jaime G. Deville,2 Chrisna Andersen,3 Elizabeth McFarland,4 Janet S. Chen,5 Shirley Li,6 Heather Maxwell,6 Vinicius A. Vieira,6 Kathryn Kersey,6 Elizabeth Castaño,7 Mark F. Cotton8
1Wits VIDA-Nkanyezi, University of the Witwatersrand, Johannesburg, South Africa; 2UCLA David Geffen School of Medicine, Los Angeles, California, USA; 3Be Part Yoluntu Centre, Paarl, South Africa; 4University of Colorado School of Medicine, Children’s Hospital Colorado, Aurora, USA;
5Drexel University College of Medicine, Philadelphia, Pennsylvania, USA; 6Gilead Sciences, Inc., Foster City, California; 7Hospital del Niño, Ciudad de Panama, Panama; 8Family Centre for Research with Ubuntu (FAMCRU), Stellenbosch University, Cape Town, South Africa
![0806221copy](../images/080722/080722-1/0806221copy.gif)
![0806223copy](../images/080722/080722-1/0806223copy.gif)
![0806222copy](../images/080722/080722-1/0806222copy.gif)
![0806223copy](../images/080722/080722-1/0806223copy.gif)
![0806224copy](../images/080722/080722-1/0806224copy.gif)
![0806225copy](../images/080722/080722-1/0806225copy.gif)
![0806226copy](../images/080722/080722-1/0806226copy.gif)
![0806227copy](../images/080722/080722-1/0806227copy.gif)
![0806228copy](../images/080722/080722-1/0806228copy.gif)
![0806229copy](../images/080722/080722-1/0806229copy.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|